• VSee Health corrected its proposed reverse stock split cap to a maximum 80-for-1 from up to 250-for-1.
• The revised limit remains subject to regulatory requirements and shareholder approval, aimed at supporting its Nasdaq listing.
• The company terminated its previously announced standby equity purchase agreement, leaving no active equity facility expected to drive near-term dilution.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VSee Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202607220830ACCESSWRNAPR_____1194607) on July 22, 2026, and is solely responsible for the information contained therein.